Tumors of the liver in children

Surgical Oncology

Volumn 16, Issue 3, 2007, Pages 195-203

  Meyers, Rebecka L ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Biliary rhabdomyosarcoma; Focal nodular hyperplasia; Hepatic sarcoma; Hepatoblastoma; Hepatocellular carcinoma; Infantile hemangioma; Mesenchymal hamartoma; Pedfiatric liver tumors; Rhabdoid tumor; Undifferentiated sarcoma

Indexed keywords

ALPHA FETOPROTEIN; ALPHA2 INTERFERON; AMIFOSTINE; AMINOCAPROIC ACID; CARBOPLATIN; CISPLATIN; CONTRAST MEDIUM; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DIGITALIS; DIURETIC AGENT; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FUMAGILLOL CHLOROACETYLCARBAMATE; IFOSFAMIDE; IRINOTECAN; LOW MOLECULAR WEIGHT HEPARIN; PIRARUBICIN; TRANEXAMIC ACID; VINCRISTINE;

AGE DISTRIBUTION; ANEMIA; ANGIOSARCOMA; BILIARY RHABDOMYOSARCOMA; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; HAMARTOMA; HEPATOBLASTOMA; HUMAN; INFANTILE HEMANGIOMA; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER LOBECTOMY; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LUNG METASTASIS; LUNG SURGERY; MESENCHYMAL HAMARTOMA; MONOTHERAPY; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOTOXICITY; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RELAPSE; REVIEW; RHABDOID TUMOR; RHABDOMYOSARCOMA; SURVIVAL TIME; TERATOMA; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LIVER NEOPLASMS;

EID: 36048993472     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.07.002     Document Type: Review

References (69)

1. Von Schweinitz D. Management of liver tumors in childhood. Seminar in Pediatric Surgery 15 (2006) 17-24
2. Prokurat A., Kluge P., Kosciesza A., et al. Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Medical and Pediatric Oncology 39 (2002) 510-518
3. Stringer M.D. Liver tumors. Seminar in Pediatric Surgery 9 (2000) 196-208
4. Owe T., Kubota A., Okuyama H., et al. Hepatoblastoma in children of extremely low birth weight: a report from a single prenatal center. Journal of Pediatric Surgery 38 (2003) 134-137
5. Malogolowkin M.H., Katzenstein H.M., Krailo M., et al. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. Journal of Clinical Oncology 24 (2006) 2879-2884
6. Haas J.E., Feusner J.H., and Finegold M.J. Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer 92 (2001) 3130-3134
7. Meyers R.L., Katzenstein H.M., Rowland J.H., et al. PRETEXT and other prognostic factors in hepatoblastoma. Pediatric Blood Cancer (2008) in press
8. Meyers R.L., McGahren E., Malogolowkin, et al. Pulmonary metastasectomy in children with hepatoblastoma. Journal of Pediatric Surgery (2008) in press
9. Aretz S., Koch A., Uhlhaas S., et al. Pediatric Blood Cancer 47 (2006) 811-818
10. Hirschman B.A., Pollock B.H., and Tomlinson G.E. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. Journal of Pediatrics 147 (2005) 263-266
11. Tomlinson G.E., Douglass E.C., Pollock B.H., et al. Cytogenetic analysis of a large series of hepatoblastoma: numerical aberrations with recurring translocations involving 1q12-21. Genes Chromosomes Cancer 44 (2006) 177-184
12. Meyers R.L., Katzenstein H.M., and Malogolowkin M.H. Predictive value of staging systems in hepatoblastoma. Journal of Clinical Oncology 25 (2007) 737-738
13. Perilongo G. State of the art: Treatment of childhood liver tumors. In: 38th annual meeting of SIOP. Geneva, Switzerland; 2006
14. Katzenstein HM, Krailo M, Malogolowkin MH, et al. Biology and treatment of children with all stages of hepatoblastoma: COG proposal AHEP-0731, submitted to CTEP and NCI February 2007.
15. Katzenstein H.M., Krailo M.D., Malogolowkin M.H., et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric oncology group and the children's cancer group study. Journal of Clinical Oncology 29 (2002) 2980-2997
16. Aronson D.C., Schnater J.M., Staalman C.R., et al. Predictive value of the Pretreatment extent of disease system in hepatoblastoma: results from the international society of pediatric oncology liver tumor study group SIOPEL-1 study. Journal of Clinical Oncology 23 (2005) 1245-1252
17. Ortega J.A., Douglass E.C., Feusner J.H., et al. Randomized comparison of cisplatin/vincristin/5-fluorouracil and cisplatin/doxorubicin for the treatment of pediatric hepatoblastoma (HB): a report from the Children's cancer group and the pediatric oncology group. Journal of Clinical Oncology 18 (2000) 2665-2675
18. Perilongo G., Shafford E., Maibach R., et al. Risk adapted treatment for childhood hepatoblastoma: final report of the second study of the internal society of pediatric oncology, SIOPEL 2. European Journal of Cancer 40 (2004) 411-421
19. Fuchs J., Rydzynski J., vonSchweinitz D., et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German cooperative pediatric liver tumor study HB94. Cancer 95 (2002) 172-182
20. Hishiki, et al. Japanese Study group for pediatric liver tumors, JPLT-2. In: First international symposium childhood hepatoblastoma. Poland: Gdansk; March 2007.
21. Malogolowkin MH, Katzenstein HM, Krailo M, et al. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. Journal of Clinical Oncology, in press.
22. Von Schweinitz D, Haberle B. German liver tumor study: HB 99. In: First international symposium childhood hepatoblastoma. Poland: Gdansk; March 2007.
23. Von Schweinitz D., Hecker H., Harms D., et al. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma-a report fro the German cooperative pediatric liver tumor study HB-89. Journal of Pediatric Surgery 30 (1995) 845-852
24. Muldoon L.L., Pagel M.A., Kroll R.A., et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clinical Cancer Research 6 (2000) 309-315
25. Otte J.B., deVille de Goyet J., and Reding R. Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatric Transplantation 9 (2005) 557-656
26. Chardot C., Sant Martin C., Gilles A., et al. Living related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma. Transplantation 73 (2002) 90-92
27. Czauderna P., Otte J.B., Aronson D.C., et al. Guidelines for surgical treatment of hepatoblastoma in the modern era : recommendations from the childhood liver tumour strategy group of the international society of paediatric oncology (SIOPEL). European Journal of Cancer 41 (2005) 1031-1036
28. Czauderna P., MacKinley G., Perilongo G., et al. Hepatocellular carcinoma in children: results of the first prospective study of the international society of pediatric oncology group. Journal of Clinical Oncology 20 (2002) 2798-2804
29. Dall'Igna P., Cecchetto G., Toffolutti T., et al. Multifocal hepatoblastoma: is there a place for partial hepatectomy?. Medical and Pediatric Oncology 40 (2003) 113-117
30. Millar A.J.W., Hartley P., Khan D., et al. Extended hepatic resection with transplantation back-up for an unresectable tumor. Pediatric Surgery International 17 (2001) 378-381
31. Katzenstein H.M., Krailo M.D., Malogolowkin M.H., et al. Fibrolamellar hapatocellular carcinoma in children and adolescents. Cancer 97 (2003) 2006-2012
32. Gille J., Spieth K., and Kaufmann R. Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer. Journal of Deutsch Dermatologische Gesellschaft 3 (2005) 26-32
33. Meng F., Henson R., and Patel T. Chemotherapeutic stress selectively activates NF-kappa B dependent Akt and VEGF expression in liver cancer derived endothelial cells. American Journal of Physiology-Cell Physiology 30 (2007) Epub
34. Pang R., and Poon R.T. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Letters 242 (2006) 151-167
35. Weitz J., Klimstra D.S., Cymes K., et al. Management of primary liver sarcomas. Cancer 109 (2007) 1391-1396
36. Spunt S.L., Lobe T.E., Pappo A., et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. Journal of Pediatric Surgery 35 (2000) 309-316
37. Awan S., Davenport M., Portmann B., et al. Angiosarcoma of the liver in children. Journal of Pediatric Surgery 31 (1996) 1729-1732
38. Nazir Z., and Pervez S. Malignant vascular tumors of liver in neonates. Journal of Pediatric Surgery 41 (2006) e49-e51
39. Ravindra K.V., Cullinane C., Lewis I.J., et al. Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. Journal of Pediatric Surgery 37 (2002) 1488-1490
40. Clairotte A., Ringenbach R., Laithier V., et al. Malignant rhabdoid tumor of the liver with spontaneous rupture : a case report. Annales De Pathologie 26 (2006) 122-125
41. Baron P.W., Majiessipour F., Bedros A.A., et al. Undifferentiated embryonal sarcoma of the liver successfully treated with chemotherapy and liver resection. Journal of Gastrointestinal Surgery 11 (2007) 73-75
42. Bisogno G., Pilz T., Perilongo G., et al. Undifferentiated sarcoma of the liver in childhood: a curable disease. Cancer 94 (2002) 252-257
43. Kim D.Y., Kim K.H., Jung S.E., et al. Undifferentiated (embryonal) sarcoma of the liver: combination treatment by surgery and chemotherapy. Journal of Pediatric Surgery 37 (2002) 1419-1423
44. Meyers R.L., and Scaife E.R. Benign liver and biliary tract masses in infants and toddlers. Seminar in Pediatric Surgery 9 (2000) 145-146
45. Daller J., Bueno J., Guitierrez J., et al. Hepatic hemangioendothelioma: clinical experience and management strategy. Journal of Pediatric Surgery 34 (1999) 98-106
46. Davenport M., Hansen L., Heaton N., et al. Hemangioendothelioma of the liver in infants. Journal of Pediatric Surgery 30 (1995) 44-48
47. Warrell R., and Kemping J. Treatment of severe coagulopathy in Kasabach Merritt syndrome with amino-caproic acid and cryoprecipitate. New England Journal of Medicine 313 (1985) 309-312
48. Morad A., McClain K., and Ogden A. The role of tranexamic acid in the treatment of giant hemangiomas in newborns. Journal of Pediatric Hematology Oncology 15 (1993) 383-385
49. Teillac-Hamel D., DeProst Y., Bodemer C., et al. Serious childhood angiomas: unsuccessful alfa interferon treatment report of four cases. British Journal of Dermatology 129 (1993) 473-476
50. Perez-Payarols J., Pardo-Masferrer J., and Gomea-Bellvert C. Treatment of life threatening hemangiomas with vincristine. New England Journal of Medicine 333 (1985) 69
51. Al-Rashid R. Cyclophosphamide and radiation therapy in the treatment of disseminated intravascular clotting. Cancer 27 (1971) 364-368
52. Manglani M., Chari G., Shama U., et al. Successful treatment with cyclophosphamide in a large hepatic hemangioendothelioma. Indian Pediatrics 31 (1994) 875-877
53. Woltering M., Robben S., and Egeler R. Hepatic hemangioendothelioma of infancy: treatment in interferon alpha. Journal of Pediatric Gastroenterology and Nutrition 24 (1997) 348-351
54. Huang S.A., Tu H.M., Harney J.W., et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. New England Journal of Medicine 343 (2000) 185-189
55. Lee T.C., Barshes N.R., Agee E.E., et al. Resolution of medically resistant hypothyroidism after liver transplantation for hepatic hemagioendothelioma. Journal of Pediatric Surgery 41 (2006) 1783-1785
56. Diamond IR, et al. Multimodal management of massive hepatic hemangioma. In: Presented at American Pediatric Surgical Association Annual Meeting, Orlando FL May 2007. Journal of Pediatric Surgery, in press.
57. Christison-Lagay E.R., Burrows P.E., Alomari A., et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. Journal of Pediatric Surgery 42 (2007) 62-68
58. Stringer M.D., and Alizai N.K. Mesenchymal hamartoma of the liver: a systematic review. Journal of Pediatric Surgery 40 (2005) 1681-1690
59. Barnhart D., Hirschl R., Garver K., et al. Conservative management of mesenchymal hamartoma of the liver. Journal of Pediatric Surgery 32 (1997) 1495-1498
60. Reymond D., Plaschkes J., Ridolfi-Luthy A., et al. Focal nodular hyperplasia of the liver in children: Review of follow-up and outcome. Journal of Pediatric Surgery 30 (1995) 1590-1593
61. Tanasecu D., Hurwitz C., and Waxman A. Scintigraphic findings mimicking focal nodular hyperplasia in a case of hepatoblastoma. Clinical Nuclear Medicine 16 (1991) 236-238
62. Belghiti J., Paterson D., Panis Y., et al. Resection of presumed benign liver tumors. British Journal of Surgery 80 (1993) 380-383
63. Herman P., Pugliese V., Machado M.A., et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World Journal of Surgery 24 (2000) 372-376
64. Rocourt D.V., Shiels W.E., Hammond S., et al. Contemporary management of benign hepatic adenoma using percutaneous radiofrequency ablation. Journal of Pediatric Surgery 41 (2006) 1149-1152
65. Todani T., Tabuchi K., Watanabe Y., et al. True hepatic teratoma with high serum alpha fetoprotein in serum. Journal of Pediatric Surgery 12 (1997) 591-592
66. Roebuck D.J., Aronson D., Clapuyt P., et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatric Radiology 37 (2007) 123-132
67. Schnater J.M., Aronson D.C., Plaschkes J., et al. Surgical view of the treatment of patients with hepatoblastoma. Cancer 94 (2002) 1111-1120
68. vonSchweinitz D. German cooperative trials for hepatoblastoma. Presented at: First International Symposium Childhood Hepatoblastoma (March 2007), Gdansk, Poland
69. Leary D., Weiskittel D., Blane C., et al. Follow-up imaging of benign pediatric liver tumors. Pediatric Radiology 19 (1989) 234-236